Related Experiment Video
Updated: May 28, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
Published on: April 2, 2021
Candida albicans infections in renal transplant recipients: effect of caspofungin on polymorphonuclear cells
Valeria Allizond1, Giuliana Banche, Franca Giacchino
1Department of Public Health and Microbiology, Microbiology Section, University of Turin, Via Santena 9, 10126 Turin, Italy.
Abstract:
This study aimed to compare the caspofungin immunomodulating activities against Candida albicans on polymorphonuclear cells (PMNs) from renal transplant recipients (RTRs) and healthy subjects (HSs). RTR PMNs showed a significantly reduced fungicidal activity compared with that of HS PMNs. Addition of caspofungin to RTR PMNs significantly potentiated the yeast intracellular killing rate, achieving values similar to those observed for HS PMNs. These data show that caspofungin is suitable for invasive candidiasis treatment in patients with immune system-impaired components.
Insights
Caspofungin enhances immune cell activity in renal transplant recipients, improving their ability to fight Candida albicans. This suggests caspofungin is effective for invasive candidiasis in immunocompromised patients.
Area of Science:
- Immunology
- Mycology
- Transplantation
Background:
- Renal transplant recipients (RTRs) often have impaired immune function, increasing susceptibility to fungal infections like invasive candidiasis.
- Polymorphonuclear cells (PMNs) are crucial for combating fungal pathogens, but their function can be compromised in RTRs.
Purpose of the Study:
- To compare the immunomodulating effects of caspofungin on PMNs from RTRs versus healthy subjects (HSs) against Candida albicans.
- To assess the efficacy of caspofungin in restoring fungicidal activity in RTR PMNs.
Main Methods:
- Collected PMNs from RTRs and HSs.
- Assessed fungicidal activity against Candida albicans with and without caspofungin.
- Compared killing rates between the two groups.
Main Results:
- RTR PMNs exhibited significantly reduced fungicidal activity compared to HS PMNs.
- Caspofungin addition significantly enhanced the intracellular killing rate of Candida albicans by RTR PMNs.
- Restored RTR PMN fungicidal activity reached levels comparable to those of HS PMNs.
Conclusions:
- Caspofungin demonstrates potent immunomodulating activity, restoring impaired PMN function in RTRs.
- The findings support the suitability of caspofungin for treating invasive candidiasis in immunocompromised patients, including RTRs.
Related Concept Videos
Cryptococcal Meningitis
Candidiasis
Fungal Phylum Microsporidia
Kidney Transplant II: Surgical Procedure
Antifungal Agents

